Synopsys, Inc. (NASDAQ:SNPS) Position Boosted by Crossmark Global Holdings Inc.

Crossmark Global Holdings Inc. lifted its stake in Synopsys, Inc. (NASDAQ:SNPS) by 6.2% in the fourth quarter, Holdings Channel.com reports. The firm owned 9,652 shares of the semiconductor company’s stock after acquiring an additional 563 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in Synopsys were worth $4,685,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in SNPS. Pacifica Partners Inc. purchased a new stake in Synopsys in the 3rd quarter worth approximately $25,000. Kieckhefer Group LLC acquired a new stake in Synopsys in the fourth quarter valued at approximately $27,000. Tsfg LLC boosted its holdings in Synopsys by 75.0% in the third quarter. Tsfg LLC now owns 56 shares of the semiconductor company’s stock worth $28,000 after purchasing an additional 24 shares in the last quarter. Hazlett Burt & Watson Inc. boosted its holdings in Synopsys by 40.0% in the third quarter. Hazlett Burt & Watson Inc. now owns 70 shares of the semiconductor company’s stock worth $35,000 after purchasing an additional 20 shares in the last quarter. Finally, Princeton Global Asset Management LLC bought a new position in Synopsys during the third quarter valued at about $44,000. 85.47% of the stock is currently owned by institutional investors and hedge funds.

Synopsys Trading Up 2.8 %

SNPS stock opened at $544.70 on Thursday. The firm has a market cap of $84.20 billion, a P/E ratio of 37.51, a P/E/G ratio of 3.45 and a beta of 1.12. Synopsys, Inc. has a 1-year low of $457.52 and a 1-year high of $629.38. The business’s 50 day moving average is $518.37 and its 200-day moving average is $524.33.

Insiders Place Their Bets

In other news, CRO Richard S. Mahoney sold 20,838 shares of the business’s stock in a transaction that occurred on Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total value of $10,544,236.38. Following the transaction, the executive now directly owns 1,460 shares of the company’s stock, valued at $738,774.60. The trade was a 93.45 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.66% of the company’s stock.

Analyst Ratings Changes

SNPS has been the subject of several recent analyst reports. Rosenblatt Securities reiterated a “buy” rating and set a $635.00 price target on shares of Synopsys in a research note on Wednesday, December 4th. Needham & Company LLC reiterated a “buy” rating and set a $640.00 price target on shares of Synopsys in a report on Thursday, December 5th. Berenberg Bank assumed coverage on shares of Synopsys in a research note on Tuesday, October 15th. They issued a “buy” rating and a $660.00 price objective for the company. Robert W. Baird lowered their target price on shares of Synopsys from $644.00 to $630.00 and set an “outperform” rating on the stock in a research note on Thursday, December 5th. Finally, Mizuho initiated coverage on shares of Synopsys in a report on Tuesday, October 22nd. They set an “outperform” rating and a $650.00 price target for the company. One investment analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. According to MarketBeat, Synopsys presently has a consensus rating of “Moderate Buy” and an average price target of $641.82.

About Synopsys

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.